chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive COVID-19 test with symptoms; nerve problem on right leg created drop foot, due to being in bed for 5 weeks; This is a spontaneous report from a contactable consumer (Patient). A 70-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FL9269), dose 1 via an unspecified route of administration on 08Feb2021 15:00 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient got the shot and had no symptoms before the shot, got very sick that week and became progressively worse after the shot. he was okay for the first couple of days and then he got sicker and sicker and weaker and weaker. Patient went to the ER on 15Feb2021, and he got a positive Covid test on 15Feb2021. He went into the hospital on 17Feb2021 because he was very weak and had a fever (Low grade fever until the time he was admitted to hospital) and he was in hospital for 6 days(Till 22Feb29021). Patient was all better now and he was treated with Remdesivir. he was in bed and weak for 5 weeks, he developed a nerve problem on his right leg on 21Mar2021. States it was created by the nerve thing, it is called drop foot, it improved slightly. Patient had took treatment for the event as IV, Remdesivir 4 Day Program, he was in the hospital for 6 days they gave him the Remdesivir plus antibiotics and other things that he doesn't know off the top of his head. Patient tested negative for Covid at the end of March. The outcome was recovered with sequels for the event covid-19 and for other it was recovering.
Headache for 5 days,  a feeling of ?brain fog?.  Minimal activity.      After 5 days it went away and felt fine.  After 2nd dose -  that night started with chills, warm flushed feeling, all over body aches, headache.  These lasted two days then went away.  Feel fine now.
Right arm redness 1 day after V2V vaccine given. No antihistamine given. Area red, approx 1 1/2 inches across, warm to touch, no systemic symptoms.
FEVER, RESPIRATORY DISTRESS-WHEEZING, VERY SHORT OF BREATH,  NEEDING OXYGEN AND NEBULIZER TREATMENT, RESCUE INHALER; CROUPY COUGH THAT LASTED MORE THAN 4 MONTHS.
Rash on right forearm. Has spread to 2 inch by 2 inch over 3 months
DEVELOPED PAINFUL SORE IN ONE AXILLA THE MORNING AFTER ADMINISTRATION.  (PT DID NOT RECALL WHICH SIDE IT DEVELOPED INITIALLY).  THEN DEVELOPED SMALLER "MOSQUITO BITE" SIZED BUMPS ON STOMACH AND BUTTOCKS OVER THE NEXT DAY (ABOUT 7 BUMPS IN EACH AREA).   PT ALSO HAD BODY ACHES AFTER VACCINATION.  NO FEVER.   ADVISED PT TO CHECK IN WITH PCP.
First shot: severe head pain and boy aches. No fever. Fatigued set in around 530 pm, 4.5 hours after injection. Could not sleep. Woke up and took two Extra strength Tylenol to relieve the pain and they worked.  Second shot: similar experience except, two Tylenol at 3am the next morning helped with my fever. My fever broke around 4am and came back around 9am. Severe body and head pain that lasted all day until around 330 pm. I laid in bed all day because I could not function normally. Woke up Sunday morning fatigued feeling but no head or body pain.
Pt received 2nd series of anthrax vaccine on 2/10/03. Noticed some "itching" yesterday afternoon and that he increased swelling last night. Went to immunication  and vaccine measure at approx 77mm x 87mm area. Has mild ? with subcutaneous cyst, high ?
15 mins p/vax adm, broke out in raised areas that looked like mosquito bites on rt upper chest c/o feeling flushed-BP 140/78, P96, R20, T98; rash cont to spread under breast & on rt leg over next hr;
48 hrs after the vaccine, I experienced intense pressure in my head and then hearing loss in my left ear. By the evening on April 29, I had lost almost all hearing in my left ear and was experiencing intense ringing in my left ear and pressure in my right ear. Woke up April 30th and the symptoms were worse and had lost all hearing in my left ear.
Pain around the heart; This is a spontaneous report from a non-contactable consumer (patient). A 24-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EP6955 and Expiration date: unknown), via an unknown route of administration on 09Apr2021 (at the age of 24-year-old) as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient has no known allergy. Patient did not receive any other vaccine within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and not tested for COVID-19 since the vaccination. On an unknown date, the patient experienced pain around the heart. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the event. Outcome of event was recovering.   Follow-Up (01Jul2021): Follow-up attempts are completed. No further information is expected.
Injections were given and patient walked to front office then had syncopal episode. Assisted to floor by another patient and no injury noted. Moved to patient room and vs checked. She says she feels better now and was able to stand and walk with no dizziness. Encouraged her to use caution when she gets injections or has blood drawn as she may pass out again. RN July 19, 2016 4:36 PM.
The pt developed red, swollen of 11.5 x 8cm area on deltoid.
About 19 hours after my first dose of Pfizer I woke up with a rapid drumming/thumping sound in my right ear.  The speed of the beats was fairly consistent, but the volume changed throughout the first day. The volume changes seemed to be very much correlated to my stress levels which were fairly high for obvious reasons. With every 'beat of the drum' I could feel a little twitch deep within my ear.  After reading a description of Pulsatile Tinnitus, I feel this diagnosis might be a good fit.  I have never had any ear or hearing problems in the past. So far it has continued in to the second morning after vaccination. If I am able to update this report I will update it as time goes on.  I am very anxious/depressed about the whole situation. I have very rarely felt anxiety or depression in the past. I've certainly never felt that I might have a medical issue regarding anxiety/depression. I feel this might be another side affect of the vaccine as well.
mild varicella disease symptoms with rash (papular rash, rhinorrhea, diarrhea, anorexia) with rash appearing 8 days after administration and prodrome 5 days after admin.
Child was given 12 month shots on 12/12/2003, parent denied any febrile illness in child for 7 days.  Stated allergy to amoxicillin, no reaction to any other immunizations: MMR, Varicella, Comvax, Prevnar, PPD done.  Mother states child fine until 23:30, Saturday 12/13/2003.  Parent checked on child before retiring and found child in bed covered with large urticaria, no respiratory problem.  To ER, child received epinephrine IV given Benadryl and steroid and and Benadryl for 5 days.  Child checked by pediatrician on Monday 12/15/2003, no problem
fully vax 12/24/21 1/12/21 covid pos 12/27/21
I went home immediately after having the shot and had to sleep for 2 hours.  I woke up with a headache.  The headache was gone by the next morning. Then, 3 days later I started having fecal incontinence that lasted for approximately 2 weeks.  I've also had 4 episodes where my heart felt like someone was squeezing it.  Two ofthe episodes happened in the middle of the night and woke me up.  Two episodes happened during the afternoon and evening while I was watching TV.  After the fecal incontinence subsided I felt like I was getting a UTI because I had pressure and pain that went along with an urgency to urinate.  I got on antibiotics, but that didn't help and when I gave a sample, there was no bacteria found. This went on for about 10 days and the pain and pressure finally went away. I was 60 years old when I had the Shingrix shot in June, 2020.
This spontaneous report was received from a nurse concerning an unspecified number of patients of unknown age and gender. Pertinent medical history and concurrent conditions were not reported. On an unknown date, the patients received an unspecified dose of PROQUAD (Lot # L002420; expiration date 23-JUL-2016) (route not reported), which was improperly stored. Concomitant therapies were not provided. No adverse effects were reported. This is one of two reports from the same source (MARRS # 1601USA011667). Additional information has been requested.
pt recvd vax & devel stomach ache & felt queasy the  next day after every meal; referred to PMD;
Large red hive like patch around injection site left arm. Hot to touch. Does not look like a small pox type itchy-noticed the day after shot. (Reaction around ZOSTAVAX site, not near flu shot site).
Vaccine received approx. 11am; returned home.  Felt sleepy around 3pm.  Took nap until 6:15pm. At that time, generalized joint pain and skin pain was reported, which was reported at 3-4 pain (distracting to distressing), as well as a notably stiff left arm and discomfort at injection site.  This worsened gradually until the time of this report filing at 11:42pm and has increased to 5-6 (very distressing to intense). Minor nausea, but no vomiting.  No treatment has been sought at this time.  Patient took 500mg of Acetaminophen twice. One tablet at 7:00pm and TWO tablets at 11:30pm.  We intend to seek professional medical intervention if symptoms progress further.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 72-year-old male patient who received Shingrix (batch number DD43M, expiry date March 2019) for prophylaxis. On 8th September 2018, the patient received the 1st dose of Shingrix (subcutaneous) .5 ml. On 8th September 2018, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On 9th September 2018, the patient experienced injection site erythema. On 11th September 2018, the outcome of the injection site erythema was recovered/resolved. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the injection site erythema to be related to Shingrix. Additional details were reported as follows: The healthcare professional stated the patient was inadvertently administered Shingrix vaccine subcutaneously instead of the indicated intramuscular, which led to incorrect route of vaccine administration. A red injection site reaction developed the day after vaccination. This case has been linked with US2018165484, reported by same reporter.
pt brought from RA Care facility via EMS to hospital; O2 sats 78% on RA; O2 supplementation; dx 3 days prior to hospitalization  with COVID; non-productive cough; COVID pneumonia; given remdesivir, dexamethasone, ABX; DNR; respiratory status worsened requiring BiPAP; pt did not improve; worsened; family opted for comfort measures and to remove BiPAP; pt passed away in the hospital
Arm pain for 12 hours, fever for 4+ days, aches and chills for 4+ days, sore throat for 4+ days, fatigue for 4+ days
Since Mar 29-Vertigo(Dizziness) fluctuating, more severe in AM-every day since. Tinnitus-pre-existing, now worse. Lethargy. 2 visits to Primary care doc.
patient reported bruising on left auxilia. Patient states no discomfort but states he did not have this bruising before getting the vaccine. Patient will monitor for any sign of pain or swelling and will contact pharmacy and doctor on Monday if any further symptom occur.
eXTREME LONG LASTINGADVERE EFFECTS - MAJOR FATIGUE AND BODY ACHES, HEADACHES, LOW GRADE FEVER, SOME NAUSEA AND VOMITING  - WILL BE TWO WEEKS SINCE INITIAL VAX ON MARCH 302021
Mild swelling and bump forming on left collar bone. Which happens to be the same side as the injections site, which was the left deltoid. Patient reported event to pharmacy 11/01/2021 and was instructed to contact their PCP for follow-up.
Large red, hard, itchy welt on large part of upper left arm. Very itchy , hot and swollen out. Took photos because it was abnormal. After about 7 hours, started to get fever, chills, aching joints, sore throat and very bad headache which I normally never get! The symptoms got worse in the night with delirium type symptoms. Was advised to take Tylenol to reduce the injection site pain and swelling and reduce fever and chills.
Myalgia, Arthralgia, fatigue, chills, injection site pain Narrative:
Pt recvd vax 19MAR94 & 21MAR93 exp pinhead size water blisters around inject site on both thighs covering area approx 1 to 1 1/2 diameter;
Swollen supraclavicular lymph node on left side (same side as injection). Started 24 hours after the 2nd dose. Now at 2 weeks it is still swollen and one other lymph node in same region is also swollen. Going to clinic in two days to get checked out.
New onset myasthenia gravis 2-3 weeks post first vaccine. possibly coincidence but uncertain
Suddenly became hypotensive, diaphoretic and clammy, vision got swimmy.  I was able to sit down and then lie down before passing out.  Then I got the chills and fingers were a bit cyanotic.  Blood pressure was checked--it was low 60s/40s.  Pulse ox was checked--that was fine, 99 or 100.  Temp was checked--that was also normal.  Laid down for a few hours and drank lots of fluids, (water and juice).  Blood pressure slowly came back up as the day progressed, but not back to normal.  It took two weeks for my blood pressure to fully stabilize back to my normal range.  I checked my blood pressure daily for probably three weeks and drank juice/gatorade daily to help.
Patient reported that approx 30 min after recieving the Fluvirin that she experienced excutiating pain in her right arm and shoulder. She went to her Physician's office and there she began having breathing difficulties and was given a Benadryl injection. An EKG was performed and she reported that there were no abnormalities.
This spontaneous report as received from a medical assistant refers to a 24 year old female patient. Patient's medical history and drug reactions/allergies were not reported. On 03-NOV-1990, the patient was vaccinated with MMR II dose 1 for routine. On 29-NOV-1997, the patient was vaccinated with MMR II dose 2 for routine. On 17-JAN-2014, the patient was in a car accident and sustained mild concussion. On 27-JAN-2014, the patient had titer drawn and the titer results showed that she was immune to measles and mumps but an equivocal rubella titer. No treatment was given for the adverse event. The outcome of equivocal rubella titer and the patient was in a car accident and sustained mild concussion was unknown. Additional information has been requested.
pt devel t013 then began sz activity approx 10 hr post vax was tx in ER;
Fever, chills, N/V, dehydration, ascites, gastroenteritis, elevated liver enzymes x1 week Tx-IV fluids, NSAIDS, antiemetics
HE stated after he received his vaccine at 1301 and stood up he immediately felt dizzy and lightheaded.  His vitals were taken- 138/85, O2 sat 98% RA, HR 69 (fluctuated between 65-69).  He was given a bottle of water.  He was alert, oriented, denies pain at the injection site.  Admits to Hx of Afib which has resolved years ago, allergies to sulfur drugs and denies any other history.  He was advised to wait another 20 min for observation.  Patient also advised to diall 911 if he encounters issues later- verbalized understanding.
pain at injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 18Nov2021 (Lot number: FH8027) at the age of 52 years as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "Verbatim: Chemotherapy" (unspecified if ongoing), notes: Verbatim: Chemotherapy, Received chemotherapy 5 years ago for a duration of 1 year. There were no concomitant medications. Vaccination history included:  measles (In college there was a measles outbreak. She got the vaccine for it and had no problems). The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Nov2021, outcome "recovered" (Nov2021), described as "pain at injection site".  Follow-up attempts are completed. No further information is expected.
Patient was administered the second dose of the vaccine 10 days after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient was administered the second dose of the vaccine 10 days after the first dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Historical condition not reported.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient was administered the second dose of the vaccine 10 days after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient was administered the second dose of the vaccine 10 days after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
felt tired; Injection site itched; vaccine doses were administered 72 days apart; This is a spontaneous report received from contactable consumer. The reporter is the patient.  A 75-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 27Mar2021 15:20 (Lot number: EL8982) at the age of 75 years as dose 2, single for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included: VYZULTA (ongoing); LOSARTAN (ongoing); OXYBUTYNIN (ongoing). Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Batch/Lot number: EL3248), administration date: 15Jan2021 15:20, when the patient was 75 years old, for COVID-19 immunisation, reaction: "soreness at injection site". The following information was reported: FATIGUE (non-serious) with onset 28Mar2021, outcome "unknown", described as "felt tired"; VACCINATION SITE PRURITUS (non-serious) with onset 28Mar2021, outcome "unknown", described as "Injection site itched"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 27Mar2021 15:20, outcome "unknown", described as "vaccine doses were administered 72 days apart".  Additional information: The events did not cause admission to hospital (does not include emergency room visit without further admission.  No follow-up attempts are possible. No further information is expected.
Patient was given a booster dose of Moderna, 0.25ml, with 1 previous dose of Janssen on 6/1/2021, on 1/4/22 at 11:20am.  The vial of Moderna that was used for this dose was beyond use with an expiration of 1/4/22 at 2am.  Pt has reported no adverse effects from this dose.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Mar2021 as dose 1, single (Lot number: EN6198), in left arm, on 06Apr2021 as dose 2, single (Lot number: EP7533), in left arm, on 30Oct2021 as dose 3 (booster), single (Lot number: FG3527), in left arm and on 07May2022 at 18:30 as dose 4 (booster), single (Lot number: FJ4989) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "obesity" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; VITAMIN D NOS; MELOXICAM; TYLENOL; TYLENOL COLD & SINUS; NAPROXEN SODIUM. Past drug history included: Erythromycin, reaction(s): "Known allergies: Erythromycin", notes: Known allergies: Erythromycin. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received Paxlovid as COVID 19 Treatment from 03Aug2022 to 08Aug2022.
pt recv vax & approx 1/2hr p/feeding had abn movement & turned a blue color;
This is a spontaneous report received from a contactable other HCP (patient). A 72-year-old female patient received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# unknown), at the age of 72, in left arm left, on Jan 30, 2021, single dose, for COVID-19 immunisation (given: 9:00). The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Comirnaty), at the age of 72, left arm, on Jan 13, 2021, single dose, for COVID 19 immunisation (given: 9:00); and had a reaction(s): dizziness, fever, chills and malaise. The patient experienced vaccination site pain/pain at injection site, onset Jan 30, 2021, with outcome of recovering; and vaccination site discomfort/mild discomfort at injection site, onset 2021, with outcome of unknown. No therapeutic measures taken as a result of vaccination site pain or vaccination site discomfort. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 18-JUN-2015, the patient was vaccinated with an improperly stored dose of ZOSTAVAX lot number reported as: L011535, expiration date: 03-JUL-2016, (administration route was not reported). No concomitant therapies were reported. No adverse symptoms were reported. Additional information has been requested.
Local reaction to DTaP -leg swollen/red Noticed redness same days given 5 hrs later.
crying w/intermittent breath holding-1min; hx of eyes moving r-l; color remained pink; pt was hosp; d/u dx atypical breath holding spell
Redness and swelling to injection site. Tx. Keflex x 7 days elevate, ice pack.
really bad migraines I had to call and tell my step dad's doctor they literally stopped calling me back a social worker I yelled at my son's leading office and my son school because the headaches are so bad it feels like somebody's beating me with the hammer I can't even speak the leg pain in the stomach aches it feels like I fell down the stairs and I can't get back up I can't describe it but I'm going to emergency room I thought it was like a normal symptoms but why is it getting worse I can't speak my head hurts really bad my legs hurt my knees my stomach has been killing more like 2 -3 days after or more
Pt with severe swelling and tenderness of right thigh with 6cm X 6cm swollen, indurated area in right thigh. Pt very fussy X 3 hours with onset about 3 hours, post vax. Increased tiredness for 2 days.
Patient developed an abscess on his right thigh at the injection site. The abscess needed to be drained by an HCP and the swabbed. The fluid was captured and sent to a lab and results came back positive for MRSA. The abscess has subsided however a large red spot remains at the injection site.